ClariTrial | Search Clinical Trials

Explore/cancer oncology

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

6,320 results for “cancer oncology” · Recruiting · Phase 3 · Phase 2

Page 1 of 422

Recruiting

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Phase 3Spinal Metastases

Single-fraction spine SRSMulti-fraction spine SRS

Stanford University274 participants1 site · United StatesCompletes Dec 2028

Compare CT.gov Full analysis →

Recruiting

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Phase 2Chronic Lymphocytic LeukemiaNon-melanoma Skin Cancer (NMSC)

NicotinamidePlacebo

University of Utah86 participants1 site · United StatesCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Phase 2Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8

Biospecimen CollectionComputed TomographyCystoscopy+6 more

National Cancer Institute (NCI)111 participants163 sites · United StatesCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

Phase 2Phase 3Rectal CancerNeoadjuvant TherapiesImmune Checkpoint Therapy

Node-Sparing Radiotherapy plus Chemotherapy and PD-1 inhibitorConventional Radiotherapy plus Chemotherapy and PD-1 inhibitor

Sixth Affiliated Hospital, Sun Yat-sen University430 participants1 site · ChinaCompletes Dec 2030

Compare CT.gov Full analysis →

Recruiting

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Phase 2Esophageal Squamous Cell CarcinomaEsophageal CancerMetastatic Esophageal Squamous Cell Carcinoma

LDRT+CFRTImmunotherapyChemotherapy

Shanghai Chest Hospital100 participants2 sites · ChinaCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

Phase 1Phase 2MDS/MPN

ASTX727ItacitinibRuxolitinib

Michael Savona94 participants4 sites · United StatesCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Phase 2Myelodysplastic SyndromesCytopenia

Elritercept

Takeda160 participants53 sites · United States, Australia, CzechiaCompletes Oct 2029

Compare CT.gov Full analysis →

Recruiting

Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

Phase 1Phase 2Spine Metastases

Prophylactic RadiotherapyStandard of care systemic therapy

Baptist Health South Florida74 participants1 site · United StatesCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer

Phase 2Advanced Biliary Tract Cancer

BL-B01D1Pembrolizumab

Sichuan Baili Pharmaceutical Co., Ltd.46 participants1 site · ChinaCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

Phase 1Phase 2Metastatic Breast Cancer

LenvatinibPembrolizumaFulvestrant

Memorial Sloan Kettering Cancer Center56 participants7 sites · United StatesCompletes Nov 2027

Compare CT.gov Full analysis →

Recruiting

The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial

Phase 2Gastric (Stomach) CancerBiological TherapyImmunotherapy

RetroNectin active Killer cellsTAS-102 (trifluridine and tipiracil, Lonsurf®)

Chinese PLA General Hospital90 participants1 site · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Hypofractionated WPPT With HDR Boost

Phase 2Prostate Cancer

Hypofractionated Whole Pelvis Proton Therapy with Brachytherapy Boost

Abramson Cancer Center at Penn Medicine30 participants1 site · United StatesCompletes Jan 2034

Compare CT.gov Full analysis →

Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Phase 1Phase 2MTAP-deleted Solid Tumors

BAY 3713372

Bayer450 participants60 sites · United States, Australia, BelgiumCompletes Jun 2029

Compare CT.gov Full analysis →

Recruiting

Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial

Phase 3Small Cell Lung Carcinoma

Thoracic Radiotherapy 45 Gy BIDThoracic Radiotherapy 60 Gy BIDThoracic Radiotherapy SIB 45-54 Gy BID

Instituto de Investigación Biomédica de Salamanca300 participants13 sites · SpainCompletes Sep 2028

Compare CT.gov Full analysis →

Recruiting

Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer

Phase 2Unresectable Locally Recurrent Rectal Cancer

Stereotactic Body Radiation Therapy (SBRT)

Sixth Affiliated Hospital, Sun Yat-sen University20 participants1 site · ChinaCompletes Nov 2026

Compare CT.gov Full analysis →

1–15 of 6,320

Explore/cancer oncology

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

6,320 results for “cancer oncology” · Recruiting · Phase 3 · Phase 2

Page 1 of 422

Recruiting

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Phase 3Spinal Metastases

Single-fraction spine SRSMulti-fraction spine SRS

Stanford University274 participants1 site · United StatesCompletes Dec 2028

Compare CT.gov Full analysis →

Recruiting

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Phase 2Chronic Lymphocytic LeukemiaNon-melanoma Skin Cancer (NMSC)

NicotinamidePlacebo

University of Utah86 participants1 site · United StatesCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Phase 2Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8

Biospecimen CollectionComputed TomographyCystoscopy+6 more

National Cancer Institute (NCI)111 participants163 sites · United StatesCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

Phase 2Phase 3Rectal CancerNeoadjuvant TherapiesImmune Checkpoint Therapy

Node-Sparing Radiotherapy plus Chemotherapy and PD-1 inhibitorConventional Radiotherapy plus Chemotherapy and PD-1 inhibitor

Sixth Affiliated Hospital, Sun Yat-sen University430 participants1 site · ChinaCompletes Dec 2030

Compare CT.gov Full analysis →

Recruiting

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Phase 2Esophageal Squamous Cell CarcinomaEsophageal CancerMetastatic Esophageal Squamous Cell Carcinoma

LDRT+CFRTImmunotherapyChemotherapy

Shanghai Chest Hospital100 participants2 sites · ChinaCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

Phase 1Phase 2MDS/MPN

ASTX727ItacitinibRuxolitinib

Michael Savona94 participants4 sites · United StatesCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Phase 2Myelodysplastic SyndromesCytopenia

Elritercept

Takeda160 participants53 sites · United States, Australia, CzechiaCompletes Oct 2029

Compare CT.gov Full analysis →

Recruiting

Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

Phase 1Phase 2Spine Metastases

Prophylactic RadiotherapyStandard of care systemic therapy

Baptist Health South Florida74 participants1 site · United StatesCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer

Phase 2Advanced Biliary Tract Cancer

BL-B01D1Pembrolizumab

Sichuan Baili Pharmaceutical Co., Ltd.46 participants1 site · ChinaCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

Phase 1Phase 2Metastatic Breast Cancer

LenvatinibPembrolizumaFulvestrant

Memorial Sloan Kettering Cancer Center56 participants7 sites · United StatesCompletes Nov 2027

Compare CT.gov Full analysis →

Recruiting

The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial

Phase 2Gastric (Stomach) CancerBiological TherapyImmunotherapy

RetroNectin active Killer cellsTAS-102 (trifluridine and tipiracil, Lonsurf®)

Chinese PLA General Hospital90 participants1 site · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Hypofractionated WPPT With HDR Boost

Phase 2Prostate Cancer

Hypofractionated Whole Pelvis Proton Therapy with Brachytherapy Boost

Abramson Cancer Center at Penn Medicine30 participants1 site · United StatesCompletes Jan 2034

Compare CT.gov Full analysis →

Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Phase 1Phase 2MTAP-deleted Solid Tumors

BAY 3713372

Bayer450 participants60 sites · United States, Australia, BelgiumCompletes Jun 2029

Compare CT.gov Full analysis →

Recruiting

Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial

Phase 3Small Cell Lung Carcinoma

Thoracic Radiotherapy 45 Gy BIDThoracic Radiotherapy 60 Gy BIDThoracic Radiotherapy SIB 45-54 Gy BID

Instituto de Investigación Biomédica de Salamanca300 participants13 sites · SpainCompletes Sep 2028

Compare CT.gov Full analysis →

Recruiting

Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer

Phase 2Unresectable Locally Recurrent Rectal Cancer

Stereotactic Body Radiation Therapy (SBRT)

Sixth Affiliated Hospital, Sun Yat-sen University20 participants1 site · ChinaCompletes Nov 2026

Compare CT.gov Full analysis →

1–15 of 6,320